Other
Synucleinopathies
0
Pipeline Programs↗
2
Active Trials↗
0
Companies Involved↗
Synucleinopathies is an early-stage landscape with 0 programs across 0 companies.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
3
clinical trials
Completed1 · 33%
Active, not recruiting1 · 33%
Not yet recruiting1 · 33%
Clinical Trials
Trial Activity
Application of 18F-CP6A PET Imaging in Synucleinopathies
Not yet recruiting·UUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology·Phase 1·NCT06827821·18 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)